Polymyalgia rheumatica (PMR) is an inflammatory condition presenting as pain and stiffness in shoulder, neck and hip muscles, the underlying cause is unknown; however, recent studies have linked PMR to elevated IL-6 levels. In this interview with Prof. Bhaskar Dasgupta (Southend University Hospital NHS Foundation Trust, Southend-on-Sea, UK) we discuss the pathophysiology of PMR and the unmet needs in its treatment.
This information is brought to you by Touch Medical Media and is not sponsored by, nor a part of, the American College of Rheumatology.
The abstract ‘Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)‘ (Abstract number: 1676) was presented at the ACR Convergence, November 10–14, 2022.
Question
- Could you tell us a little about relapsing polymyalgia rheumatica (PMR) and the unmet needs in its treatment? (1:51)
Disclosures: Bhaskar Dasgupta discloses consulting for Sanofi; receiving grant/ research support from Sanofi; and receiving honoraria from Sanofi.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Gina Furnival.
Filmed in coverage of the ACR Convergence 2022.
